Belite Bio (BLTE) Return on Equity (2023 - 2026)

Belite Bio's Return on Equity history runs 4 years deep, the most recent figure standing at 0.81% for Q1 2026.

• In Q1 2026, Return on Equity rose 105.0% year-over-year to 0.81%; the TTM figure through Mar 2026 stood at 0.81% (up 105.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
• Return on Equity was 0.81% for Q1 2026 at Belite Bio, up from 1.21% in the prior quarter.
• In the past five years, Return on Equity ranged from a high of 0.81% in Q1 2026 to a low of 3.55% in Q2 2023.
• Historically, Return on Equity has averaged 2.14% across 4 years, with a median of 2.27% in 2025.
• Biggest YoY gain for Return on Equity was 190 bps in 2024; the steepest drop was 88 bps in 2024.
• A 4-year view of Return on Equity shows it stood at 1.92% in 2023, then slumped by 46 bps to 2.8% in 2024, then surged by 57 bps to 1.21% in 2025, then soared by 33 bps to 0.81% in 2026.
• The last three Return on Equity figures came in at 0.81% (Q1 2026), 1.21% (Q4 2025), and 2.27% (Q3 2025), per Business Quant data.